Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.120
+0.060 (2.91%)
At close: Sep 24, 2026, 4:00 PM EDT
2.140
+0.020 (0.94%)
After-hours: Sep 24, 2026, 7:30 PM EDT
Acrivon Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $7 | Buy | Maintains | $7 | +230.19% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 | Buy | Maintains | $8 | +277.36% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +277.36% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $19 | Buy | Maintains | $19 | +796.23% | Aug 13, 2026 |
| Gabelli No rating | Gabelli | Buy Initiates $8 | Buy | Initiates | $8 | +277.36% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |